• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多种利尿药保钾作用的对照临床研究]

[Controlled clinical research on the potassium-retaining action of various diuretic drugs].

作者信息

Giordano M P, Allegri M

出版信息

Arch Sci Med (Torino). 1976 Aug-Sep;133(3):271-6.

PMID:797349
Abstract

The potassium-retaining action was evaluated in its kaliemic reflexes, in two diuretic associations composed respectively of hydrochlorothiazide + spironolactone and hydrochlorothiazide + amiloride. The potassium intraerythrocytic levels were also determined as well as the natriuresis, the natremia and the daily diuresis. Researches carried out on a group of patients affected by congestive heart failure showed that, the diuretic efficacy being equal, the association of hydrochlorothiazide + spironolactone does not significantly interfere, at the various posologic levels, with the potassium balance. On the contrary, in this regard, the associaiton of amiloride + hydrochlorothiazide appeared to be less manageable because therapeutic dosages showed a tendency to hyperdaliemia.

摘要

通过钾血症反射,对分别由氢氯噻嗪+螺内酯和氢氯噻嗪+阿米洛利组成的两种利尿剂组合的保钾作用进行了评估。还测定了红细胞内钾水平以及利钠作用、血钠水平和每日尿量。对一组充血性心力衰竭患者进行的研究表明,在利尿效果相同的情况下,氢氯噻嗪+螺内酯组合在不同剂量水平下对钾平衡没有显著干扰。相反,在这方面,阿米洛利+氢氯噻嗪组合似乎较难控制,因为治疗剂量显示出高钠血症的倾向。

相似文献

1
[Controlled clinical research on the potassium-retaining action of various diuretic drugs].[多种利尿药保钾作用的对照临床研究]
Arch Sci Med (Torino). 1976 Aug-Sep;133(3):271-6.
2
Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.使用布美他尼治疗的高血压患者的血清微量元素水平:与氢氯噻嗪加阿米洛利的双盲对照试验。
Int J Clin Pharmacol Res. 1987;7(1):5-11.
3
Potassium-sparing diuretics and hyperkalaemia--still a problem.保钾利尿剂与高钾血症——仍是个问题。
Ir Med J. 1989 Dec;82(4):179.
4
[Modern diuretic preparations. III. Potassium-saving diuretics].[现代利尿制剂。III. 保钾利尿剂]
Ter Arkh. 1992;64(8):106-9.
5
A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.氨氯吡咪和螺内酯在利尿剂治疗的正常受试者中保钾和保镁特性的比较。
Br J Clin Pharmacol. 1993 Apr;35(4):373-8. doi: 10.1111/j.1365-2125.1993.tb04153.x.
6
[Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].保钾利尿剂(螺内酯、氨苯蝶啶、阿米洛利)
Orv Hetil. 1996 Sep 1;137(35):1907-14.
7
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.使用螺内酯治疗充血性心力衰竭患者时实验室监测的充分性。
J Am Coll Cardiol. 2005 Sep 6;46(5):845-9. doi: 10.1016/j.jacc.2005.06.010.
8
An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.一项开放性平行组研究,比较速尿/阿米洛利利尿剂与含环戊噻嗪及缓释钾的利尿剂在治疗充血性心力衰竭中的效果——一项多中心全科医疗研究。
J Int Med Res. 1990;18 Suppl 2:17B-23B.
9
[Amiloride. A clinical study of a potassium-retaining diuretic].[氨氯吡咪。一种保钾利尿剂的临床研究]
Ugeskr Laeger. 1969 Oct 16;131(42):1785-90.
10
Clinical experience with spironolactone in pediatrics.小儿使用螺内酯的临床经验。
Ann Pharmacother. 2005 May;39(5):823-8. doi: 10.1345/aph.1E618. Epub 2005 Apr 5.